Home-Based Tele-Exercise vs. Hospital-Based Exercise Programs in Patients With Prediabetes
Launched by GAZI UNIVERSITY · Mar 24, 2025
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two different exercise programs on people with prediabetes, a condition where blood sugar levels are higher than normal but not high enough to be considered diabetes. The trial compares "tele-exercise," where participants exercise at home using a heart rate monitor, with a "hospital-based exercise" program that takes place under supervision in a hospital setting. Both groups will engage in aerobic exercises, like walking, for 30 minutes a day, five days a week over three weeks. There is also a control group that will do the same exercises at home without any monitoring.
To be eligible for this study, participants need to be between 18 and 80 years old and have been diagnosed with prediabetes based on specific blood sugar tests. They should not be doing a lot of exercise already or using insulin or diabetes medications. This trial is currently active but not recruiting new participants. If someone qualifies and joins, they can expect to follow a structured exercise plan and help researchers understand how different exercise environments might affect their health, including their fitness, blood sugar control, and overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Accepting to participate in the study
- • ≥18 and \<80 years of age
- • With oral glucose tolerance test (after 75 g oral glucose) 2nd hour glucose value: 140-199 mg/dl or fasting blood glucose : 100-125 mg/dl and diagnosed as prediabetes by an endocrinologist
- Exclusion Criteria:
- • High physical activity: Performing ≥150 minutes of moderate-intensity exercise per week
- • Using insulin or oral antidiabetics
- • Presence of cardiac and physical conditions that would prevent aerobic exercise
- • Presence of neurological disease with significant sensorimotor deficit
- • Presence of active malignancy
- • Neuropsychiatric disease or condition that may prevent cooperation
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Çise C Güngör, MD
Principal Investigator
Gazi University Faculty of Medicine
Nesrin Ü Demirsoy, MD
Principal Investigator
Gazi University Faculty of Medicine
Levent Karataş, MD
Principal Investigator
Gazi University Faculty of Medicine
Muhittin M Yalçın, MD
Principal Investigator
Gazi University Faculty of Medicine
Levent A Güngör, MD
Principal Investigator
Gazi University Faculty of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported